Applied Statistics

Cell Biology: Abbott Laboratories

Total Score People Score Events Score
19 12 18
Date Event Presentation Speakers
April 6, 2013 AACR Annual Meetings Expanding the Druggable Genome Chairperson: Stephen W. Fesik, Vanderbilt University School of Medicine, Nashville, TN Stephen Fesik
The Stanley J. Korsmeyer Memorial Symposium: Targeting Cell Death Pathways for Cancer Therapy Chairperson: Anthony G. Letai, Dana-Farber Cancer Institute, Boston, MA Rod Humerickhouse
February 20, 2012 Advances and Progress in Drug Design Hit to lead with X-ray crystallography Kenton Longenecker
November 29, 2011 The 7th annual European Antibody Congress is the worldleading conference addressing critical scientific issues and strategic industry challenges associated with therapeutic mAb development. Panel session Day 3: Bispecific antibodies and antibody-drug-conjugates Tariq Ghayur
Development of dual-variable domain (DVD) - Ig technology platform: Pre-clinical evaluation of multiple distinct DVD - Ig molecules Tariq Ghayur
May 4, 2010 Biomarker World Congress 2010 Fit-For-Purpose Biomarker Assay Development and Validation* Viswanath Devanarayan
April 28, 2010 Kinase Inhibitor Chemistry Rational Mutagenesis to Support Structure-Based Drug Design: MAPKAP Kinase 2 as a Case Study Maria Argiriadi
September 19, 2009 Nature Chemical Biology Symposium 2009: Chemical Biology in Drug Discovery Session chair: Stephen Fesik
August 5, 2009 Drug Safety Strategies to De-Risk Compounds Three Case Studies of Strategic Use of Novel Technologies in Toxicology to De-risk Compounds Eric A Blomme
Conference Chair Opening Remarks Eric A Blomme
June 9, 2009 RNAi for Target Identification and Validation Cancer Target Identification and Validation by siRNA Library Screening Xiaoyu Lin
March 9, 2009 Drug Development Latin America Opportunities for Partnering and Innovation in Latin America Sonia M de Morais
December 2, 2008 2nd Annual Lead Discovery Summit 2008:--Primary & Secondary Screening Virtual screening: How predictive is it of compound success in wet screening campaigns? Steve Muchmore,
October 21, 2008 20th EORTC - NCI - AACR Symposium on "Molecular Targets and Cancer Therapeutics" Plenary session 7 Approaches for targeting protein-protein interaction Stephen Fesik
March 25, 2008 PATHWAY ANALYSIS Integration of Novel Technologies in Discovery and Early Development Toxicology Eric A Blomme
March 25, 2008 Preclinical Development Chairperson’s Remarks Eric A Blomme
Integration of Novel Technologies in Discovery and Early Development Toxicology Development Toxicology Eric A Blomme
February 7, 2008 Cell Death and Cellular Senescence Regulation of Apoptosis (Joint) Stephen Fesik
November 29, 2007 Cell Signalling and Novel Cancer Therapeutics Bcl-2 family inhibitors for the treatment of cancer Stephen Fesik
October 16, 2007 Fifth Annual RNAi for Drug Discovery and Therapeutics - Best Practices from the Bench to the Clinic Oct (16-17) RNAi DELIVERY - A THERAPEUTIC CHALLENGE (10:35-12:40) Yu Shen
RNAi DELIVERY - A THERAPEUTIC CHALLENGE: A Robust Positive-readout System for Monitoring siRNA Delivery to Tumors (12:10-12:40) Yu Shen
October 15, 2007 Thirs Annual Quantitative PCR, MicroArrays, And Biologican Validation: Capturing the Complete Biological Story (Oct 15-17) Genetic Variation vs Gene Expression (14:00-19:00) Dimitri Semizarov
Genetic Variation vs Gene Expression: Biomarker Identification Using Comparative Genomic Hybridization (14:35-15:05) Dimitri Semizarov
September 17, 2007 Biomarker Discovery Summit: Bridging the Silos in Biomarker Discovery & Validation (Sep17-19) Pre-Conference Workshops; Biomarker Assay Development and Validation: Part I Tutorial FIT-FOR-PURPOSE BIOMARKER ASSAY DEVELOPMENT AND VALIDATION (08:00-12:00) Viswanath Devanarayan
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.